Wednesday, 14 January 2015

Femoral Shaft Fracture

32 year old financially challenged girl with painful hip. She has a -4.bp.blogspot.com
32 year old financially challenged girl with painful hip. She has a

and colleagues examined the risk of atypical femoral fracture during and after bisphosphonate use. Radiographs of 5,342 women and men aged ≥55 years with a Femoral Shaft Fracture were reviewed; 172 patients were found to have an atypical fracture. Older women who used bisphosphonates (medications that prevent loss of bone mass) for five years or more were more likely to experience "atypical" fractures involving the femoral shaft (bone in the leg that extends from the hip to the knee) or between bisphosphonate treatment and atypical femoral fractures the authors examined data on 477 patients age 50 years and older who were hospitalized with a subtrochanteric or Femoral Shaft Fracture at a single university medical center, and a random The researchers analyzed 477 patients' data, aged 50 years and older, who were hospitalized with a subtrochanteric or Femoral Shaft Fracture with an atypical fracture, of which 32 patients or 82.1% were treated with bisphosphonates, whilst of the GENEVA, Switzerland, May 29 (UPI) -- Treatment with bisphosphonates -- drugs that offset bone loss associated with menopause -- may be linked to femur fractures in 477 patients age 50 and older who were hospitalized with a subtrochanteric or femoral Exposed individuals were defined as children who were one to three years of age when they suffered a fracture of shaft of femur, primary or secondary diagnostic code ICD: ICD-9/ICD-10: 821*/S723*. In ICD-9, fracture of femur, part unspecified, is included .

about the fractures. Merck's response, a year later, was to change the label to include the phrase "low energy femoral shaft and subtrochanteric fractures." Dr. Besser noted that the sentence was in section 6.2 on the label, on the back. Neither the FDA (SOR: C, based on case reports.) Physicians should discontinue bisphosphonate therapy in patients who have had a femoral shaft fracture or osteonecrosis of the jaw, and should consider discontinuing bisphosphonate therapy after three to five years in .


Another Picture of Femoral Shaft Fracture :



TITLE_IMG2-IMG_SRC2
TITLE_IMG2

TITLE_IMG3
TITLE_IMG3

No comments:

Post a Comment